Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Chimeric Therapeutics Ltd. has announced the cessation of 5,816,912 securities due to the lapse of conditional rights. The conditions for these securities were not met, leading to their expiration on December 20, 2024. This development might influence investor perspectives on the company’s stock performance.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.